ANR anatara lifesciences ltd

News: ANR Anatara Lifesciences Says Co Continues Licensing Talks With Potential Animal Health...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    April 7 (Reuters) - Anatara Lifesciences Ltd (ANR) :

    • CONTINUE TO ADVANCE LICENSING TALKS WITH POTENTIAL ANIMAL HEALTH PARTNERS FOR CORE ANIMAL ASSET, DETACH
    • AT CURRENT TIME, ANTICIPATES DELAY, TO SECOND HALF OF 2020, FOR COMMENCEMENT OF ITS CLINICAL TRIAL IN IRRITABLE BOWEL SYNDROME
    • DO NOT ANTICIPATE A MATERIAL DELAY OF MEETING PARTNERING MILESTONE FOR CORE ANIMAL ASSET DUE TO COVID-19
    • AIM OF MEETING PARTNERING MILESTONE OF END Q2 FOR CORE ANIMAL ASSET, DETACH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
0.002(18.2%)
Mkt cap ! $2.776M
Open High Low Value Volume
1.2¢ 1.3¢ 1.1¢ $66.18K 5.630M

Buyers (Bids)

No. Vol. Price($)
1 374339 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 540806 4
View Market Depth
Last trade - 16.10pm 08/09/2025 (20 minute delay) ?
ANR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.